{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:22:44Z","timestamp":1790140964373,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bulcan.2025.07.015","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:29:11Z","timestamp":1758760151000},"page":"S2-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Greffe de cellules-souches h\u00e9matopo\u00ef\u00e9tiques haplo-identiques dans le traitement des h\u00e9mopathies malignes en p\u00e9diatrie (SFGM-TC)"],"prefix":"10.1016","volume":"113","author":[{"given":"Anne","family":"Sirvent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Angoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berceanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"El Quessar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fabaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean S\u00e9bastien","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Ait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qamrani","family":"Fadwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"El Kababri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Paillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bulcan.2025.07.015_bib0005","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.015_bib0010","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41409-023-01943-3","article-title":"Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2\u00a0pandemic. A report from the EBMT activity survey","volume":"58","author":"Passweg","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"21","key":"10.1016\/j.bulcan.2025.07.015_bib0015","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1002\/cncr.30180","article-title":"Results of a 2-arm, phase 2\u00a0clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation","volume":"122","author":"Gaballa","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.015_bib0020","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41409-020-01074-z","article-title":"Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine\/busulfan conditioning for acute myeloid leukemia","volume":"56","author":"Bazarbachi","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.015_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13045-023-01515-4","article-title":"Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344\u00a0patients of SFGM-TC registry","volume":"17","author":"Lacan","year":"2024","journal-title":"J Hematol Oncol"},{"issue":"24","key":"10.1016\/j.bulcan.2025.07.015_bib0030","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1182\/blood.2023023697","article-title":"Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT","volume":"143","author":"Sanz","year":"2024","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bulcan.2025.07.015_bib0035","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41409-023-02085-2","article-title":"Reduced post-transplant cyclophosphamide dose with antithymocyte globulin in peripheral blood stem cell haploidentical transplantation","volume":"58","author":"Dul\u00e9ry","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"18","key":"10.1016\/j.bulcan.2025.07.015_bib0040","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1182\/bloodadvances.2023010281","article-title":"Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias","volume":"7","author":"Fierro-Pineda","year":"2023","journal-title":"Blood Adv"},{"issue":"16","key":"10.1016\/j.bulcan.2025.07.015_bib0045","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1182\/bloodadvances.2020001648","article-title":"Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults","volume":"4","author":"Symons","year":"2020","journal-title":"Blood Adv"},{"issue":"12S","key":"10.1016\/j.bulcan.2025.07.015_bib0050","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.bulcan.2021.01.024","volume":"108","author":"Dubois","year":"2021","journal-title":"Bull Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.015_bib0055","doi-asserted-by":"crossref","first-page":"424e1","DOI":"10.1016\/j.jtct.2021.01.016","article-title":"Outcomes of unmanipulated haploidentical transplantation using post-transplant cyclophosphamide (PT-Cy) in pediatric patients with acute lymphoblastic leukemia","volume":"27","author":"Ruggeri","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.015_bib0060","doi-asserted-by":"crossref","first-page":"e30255","DOI":"10.1002\/pbc.30255","article-title":"Total body irradiation-free haploidentical peripheral blood stem cell transplantation compared to related and unrelated donor transplantation in pediatrics with acute lymphoblastic leukemia","volume":"70","author":"Mardani","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.015_bib0065","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41409-025-02584-4","article-title":"Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE","volume":"60","author":"Calvo","year":"2025","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2025.07.015_bib0070","doi-asserted-by":"crossref","first-page":"1140637","DOI":"10.3389\/fped.2023.1140637","volume":"11","author":"Moreno","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.bulcan.2025.07.015_bib0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fped.2020.00282","article-title":"T-Cell replete myeloablative haploidentical bone marrow transplantation is an effective option for pediatric and young adult patients with high-risk hematologic malignancies","volume":"8","author":"Katsanis","year":"2020","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.bulcan.2025.07.015_bib0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbmt.2016.11.016","article-title":"Nonmyeloablative haploidentical bone marrow transplantation with post-transplantation cyclophosphamide for pediatric and young adult patients with high-risk hematologic malignancies","volume":"23","author":"Klein","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.015_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.20.02529","article-title":"Total body irradiation or chemotherapy conditioning in childhood all: a multinational, randomized, noninferiority phase III study","volume":"39","author":"Peters","year":"2021","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.bulcan.2025.07.015_bib0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41409-019-0607-0","article-title":"Haploidentical hematopoietic stem cell transplantation with \u03b1\u03b2TCR+\/CD19+ depletion in pediatric patients with malignant and non-malignant disorders","volume":"54","author":"Bielorai","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.bulcan.2025.07.015_bib0095","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/bloodadvances.2021005492","article-title":"Unrelated donor \u03b1\/\u03b2 T cell- and B cell-depleted HSCT for the treatment of pediatric acute leukemia","volume":"6","author":"Leahy","year":"2022","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.015_bib0100","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.bbmt.2019.01.023","article-title":"\u03b1\u03b2 T cell-depleted haploidentical hematopoietic stem cell transplantation without antithymocyte globulin in children with chemorefractory acute myelogenous leukemia","volume":"25","author":"Shelikhova","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2025.07.015_bib0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fimmu.2019.00189","article-title":"Individualization of hematopoietic stem cell transplantation using alpha\/beta T-Cell depletion","volume":"10","author":"R\u00e5destad","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.07.015_bib0110","doi-asserted-by":"crossref","first-page":"e13517","DOI":"10.1111\/petr.13517","article-title":"TCR \u03b1+ \u03b2+\/CD19+ cell-depleted hematopoietic stem cell transplantation for pediatric patients","volume":"23","author":"Mitchell","year":"2019","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.015_bib0115","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41409-020-01081-0","article-title":"HLA-haplotype loss after TCR\u03b1\u03b2\/CD19-depleted haploidentical HSCT","volume":"56","author":"Shyr","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.015_bib0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.2023021336","article-title":"TCR\u03b1\u03b2\/CD19\u00a0cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis","volume":"143","author":"Merli","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bulcan.2025.07.015_bib0125","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1182\/blood-2014-03-563817","article-title":"HLA-haploidentical stem cell transplantation after removal of \u03b1\u03b2+ T and B cells in children with nonmalignant disorders","volume":"124","author":"Bertaina","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bulcan.2025.07.015_bib0130","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"11S","key":"10.1016\/j.bulcan.2025.07.015_bib0135","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"7","key":"10.1016\/j.bulcan.2025.07.015_bib0140","first-page":"2122","article-title":"Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study","volume":"109","author":"Ruggeri","year":"2024","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.bulcan.2025.07.015_bib0145","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/bloodadvances.2021004462","article-title":"Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning","volume":"5","author":"Wagner","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.bulcan.2025.07.015_bib0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ajh.25661","article-title":"Haploidentical transplantation in high-risk pediatric leukemia: a retrospective comparative analysis on behalf of the Spanish working group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)","volume":"95","author":"P\u00e9rez-Mart\u00ednez","year":"2020","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.07.015_bib0155","doi-asserted-by":"crossref","first-page":"158e1","DOI":"10.1016\/j.jtct.2021.11.009","article-title":"Outcome of haploidentical peripheral blood allografts using post-transplantation cyclophosphamide compared to matched sibling and unrelated donor bone marrow allografts in pediatric patients with hematologic malignancies: a single-center analysis","volume":"28","author":"Srinivasan","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"11","key":"10.1016\/j.bulcan.2025.07.015_bib0160","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/pbc.26131","article-title":"Haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide in children and adolescents with hematological malignancies","volume":"63","author":"Gonz\u00e1lez-Llano","year":"2016","journal-title":"Pediatr Blood Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T13:03:42Z","timestamp":1779282222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125003881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0007455125003881"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.07.015","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Greffe de cellules-souches h\u00e9matopo\u00ef\u00e9tiques haplo-identiques dans le traitement des h\u00e9mopathies malignes en p\u00e9diatrie (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}